Novel Dense Hollow Fiber for Blood-Gas Exchange

Information

  • Research Project
  • 6751208
  • ApplicationId
    6751208
  • Core Project Number
    R44HL068375
  • Full Project Number
    5R44HL068375-03
  • Serial Number
    68375
  • FOA Number
  • Sub Project Id
  • Project Start Date
    2/15/2002 - 22 years ago
  • Project End Date
    2/28/2006 - 18 years ago
  • Program Officer Name
    BALDWIN, TIM
  • Budget Start Date
    6/1/2004 - 20 years ago
  • Budget End Date
    5/31/2005 - 19 years ago
  • Fiscal Year
    2004
  • Support Year
    3
  • Suffix
  • Award Notice Date
    4/9/2004 - 20 years ago
Organizations

Novel Dense Hollow Fiber for Blood-Gas Exchange

[unreadable] DESCRIPTION (provided by applicant): [unreadable] We have devised a technique that will greatly simplify and make cost effective the fabrication of dense silicone membrane hollow fibers (SMHF) for use in blood gas exchange applications including long-term extracorporeal life support, implantable artificial lung, and other cardiorespiratory procedures. The SMHF can be used to make non-porous, high performing, and economically attractive compact oxygenators, analogous to microporous membrane hollow fiber (MMHF) devices. Current devices using MMHF are prevalent because of enhanced gas exchange due to the convective mixing induced by blood flowing over thousands of tiny hollow fibers. This property allows for designing highly efficient gas exchange devices in relatively compact volumes. Yet MMHF suffer from fowling, and plasma leakage when they are used for extended periods of time, and from gas embolization when the gas side pressure exceeds the blood side pressure. Nonetheless there is currently no analogous non-microporous hollow fiber oxygenators. The present SMHF incorporates the compactness and effectiveness of MMHFs plus the ability to withstand plasma leakage and gas embolization. In Phase 1 we demonstrated that the SMHF can be fabricated continuously and reliably using our proprietary process, and that test oxygenating modules using our SMHF perform comparably to the MMHF counterparts. In Phase 2 we propose to further develop and scale-up the fabrication technique to evaluate the gas exchange, hemodynamic performance, and resistance to plasma breakthrough of the SMHF in adult size oxygenators. These studies will be performed on the bench as well as in-vivo. [unreadable] [unreadable]

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R44
  • Administering IC
    HL
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    428791
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:428791\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    MEDARRAY, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    ANN ARBOR
  • Organization State
    MI
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    48103
  • Organization District
    UNITED STATES